Search This Blog

Monday, May 4, 2026

GeneDx Q1 2026 EPS , revenue $102.3M miss, cuts 2026 revenue guidance

 

GeneDx Q1 2026 EPS -$0.28 (-202% YoY), revenue $102.3M (+17% YoY) miss estimates and company cuts 2026 revenue guidance to $475–$490M

  • Q1 2026 adjusted net loss was $8.2M for the quarter.
  • New 2026 outlook replaces prior positive earnings expectation with guidance for about $5M adjusted net loss.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)